View in EDS HTML Full Text PDF Full Text

Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma.

Saved in:
Bibliographic Details
Title: Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma.
Authors: Shah B; Moffitt Cancer Center, Tampa, FL, USA., Challagulla S; BeOne Medicines, San Carlos, CA, USA., Xu S; BeOne Medicines Ltd, Shanghai, China., Williams R; BeOne Medicines, San Carlos, CA, USA., Ren S; ConnectHEOR Ltd, London, UK.; SCHARR, University of Sheffield, Sheffield, UK., Srivastava T; ConnectHEOR Ltd, London, UK., Gautam R; ConnectHEOR Ltd, London, UK., Yang K; BeOne Medicines, San Carlos, CA, USA., Saba NS; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, LA, USA., Tam CS; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2238-2248. Date of Electronic Publication: 2025 Sep 01.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40889741
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shah+B%22">Shah B</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Challagulla+S%22">Challagulla S</searchLink>; BeOne Medicines, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Xu+S%22">Xu S</searchLink>; BeOne Medicines Ltd, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Williams+R%22">Williams R</searchLink>; BeOne Medicines, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ren+S%22">Ren S</searchLink>; ConnectHEOR Ltd, London, UK.; SCHARR, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Srivastava+T%22">Srivastava T</searchLink>; ConnectHEOR Ltd, London, UK.<br /><searchLink fieldCode="AU" term="%22Gautam+R%22">Gautam R</searchLink>; ConnectHEOR Ltd, London, UK.<br /><searchLink fieldCode="AU" term="%22Yang+K%22">Yang K</searchLink>; BeOne Medicines, San Carlos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Saba+NS%22">Saba NS</searchLink>; Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, LA, USA.<br /><searchLink fieldCode="AU" term="%22Tam+CS%22">Tam CS</searchLink>; Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2025 Dec; Vol. 66 (12), pp. 2238-2248. <i>Date of Electronic Publication: </i>2025 Sep 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40889741
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2025.2541911
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2238
    Titles:
      – TitleFull: Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shah B
      – PersonEntity:
          Name:
            NameFull: Challagulla S
      – PersonEntity:
          Name:
            NameFull: Xu S
      – PersonEntity:
          Name:
            NameFull: Williams R
      – PersonEntity:
          Name:
            NameFull: Ren S
      – PersonEntity:
          Name:
            NameFull: Srivastava T
      – PersonEntity:
          Name:
            NameFull: Gautam R
      – PersonEntity:
          Name:
            NameFull: Yang K
      – PersonEntity:
          Name:
            NameFull: Saba NS
      – PersonEntity:
          Name:
            NameFull: Tam CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1